Medincell SA (MEDCL) — Capital Reinvestment Ratio
Latest as of September 2024:
0.01x
Medincell SA (MEDCL) has a Capital Reinvestment Ratio of 0.01x as of September 2024, meaning it reinvests 0% of its operating cash flow (€21.56 Million) in capital expenditures (€195.00K). See Medincell SA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
€21.56 Million
EUR
Capital Expenditures
€195.00K
EUR
Data as of
Sep 2024
Most recent filing
Medincell SA Capital Reinvestment Ratio (2016–2025)
This chart tracks Medincell SA's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Medincell SA (2016–2025)
Year-by-year Capital Reinvestment Ratio for Medincell SA from 2016 to 2025. For live market cap and broader valuation context, see MEDCL market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | €19.46 Million | €1.66 Million | ▼ -99.5% |
| 2016 | 17.12x | €68.00K | €1.16 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow